UPDATE 1-U.S. settles 'pay for delay' fight with drugmaker Cephalon

WASHINGTON, May 28 (Reuters) - U.S. antitrust regulators have settled a long-running fight with Cephalon, now owned by Teva Pharmaceuticals, over how it resolved a patent infringement lawsuit tied to wakefulness drug Provigil, the Federal Trade Commission said on Thursday.